Eslicarbazepine API Manufacturers

Wiki Information	Eslicarbazepine API Manufacturers
Indication & Benefits	Eslicarbazepine acetate was developed to treat adult partial-onset epilepsy as an adjunctive drug or monotherapy. It is now being investigated in children. Studies consistently show that eslicarbazepine is generally effective at controlling partial-onset seizures, and it remains efficacious in long-term trials.
How To Use
Deficiency
Recommended For Better
Pregnancy Warning
Side Effects
Disclaimer	Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement.
Products